His scientific interests lie mostly in Internal medicine, Endocrinology, Genetics, Cholesterol and Diabetes mellitus. His Internal medicine study combines topics in areas such as Allele frequency and Cardiology. His Cardiology study integrates concerns from other disciplines, such as Pediatrics and Genetic testing.
As a part of the same scientific family, Robert A. Hegele mostly works in the field of Genetics, focusing on Apolipoprotein B and, on occasion, Microsomal triglyceride transfer protein and Exome sequencing. Robert A. Hegele works mostly in the field of Cholesterol, limiting it down to topics relating to Polymorphism and, in certain cases, SNP. His biological study spans a wide range of topics, including Odds ratio and Kidney disease.
Robert A. Hegele mostly deals with Internal medicine, Genetics, Endocrinology, Cholesterol and Gene. Robert A. Hegele has researched Internal medicine in several fields, including Diabetes mellitus and Cardiology. His Mutation, Single-nucleotide polymorphism, Phenotype, Allele and Candidate gene study are his primary interests in Genetics.
His Endocrinology research integrates issues from Familial partial lipodystrophy and Genotype. Robert A. Hegele works in the field of Cholesterol, focusing on Ezetimibe in particular. Robert A. Hegele is interested in Genetic variation, which is a branch of Gene.
Internal medicine, Genetics, Endocrinology, Familial hypercholesterolemia and Cholesterol are his primary areas of study. His research in Internal medicine intersects with topics in Gastroenterology and Cardiology. Robert A. Hegele specializes in Endocrinology, namely Apolipoprotein B.
His Familial hypercholesterolemia research is multidisciplinary, incorporating perspectives in Dyslipidemia and Lipoprotein. Robert A. Hegele interconnects Inflammation and Diabetes mellitus in the investigation of issues within Cholesterol. His work in the fields of Gene, such as Genetic variation, Genetic predisposition and Allele, intersects with other areas such as Lipodystrophy.
Robert A. Hegele mainly focuses on Internal medicine, Genetic testing, Hypertriglyceridemia, Dyslipidemia and Genetics. His Internal medicine study incorporates themes from Gastroenterology, Endocrinology and Cardiology. Robert A. Hegele has included themes like Mipomersen and Alipogene tiparvovec in his Endocrinology study.
Robert A. Hegele combines subjects such as Single-nucleotide polymorphism, Compound heterozygosity and Fatty acid with his study of Hypertriglyceridemia. The concepts of his Dyslipidemia study are interwoven with issues in Receptor, Familial hypercholesterolemia, Sequence analysis and Familial Chylomicronemia. The Gene, Copy-number variation, Phenotype and Transcription factor research Robert A. Hegele does as part of his general Genetics study is frequently linked to other disciplines of science, such as Nuclear lamina, therefore creating a link between diverse domains of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Biological, clinical and population relevance of 95 loci for blood lipids
Tanya M. Teslovich;Kiran Musunuru;Albert V. Smith;Andrew C. Edmondson.
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society
Borge G. Nordestgaard;M. John Chapman;Steve E. Humphries;Henry N. Ginsberg.
European Heart Journal (2013)
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A Ference;Henry N Ginsberg;Ian T. Graham;Kausik K Ray.
European Heart Journal (2017)
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)
Sonia S Anand;Salim Yusuf;Vladmir Vuksan;Sudarshan Devanesen.
The Lancet (2000)
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
Erik S. Stroes;Paul D. Thompson;Alberto Corsini;Georgirene D. Vladutiu.
European Heart Journal (2015)
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations
Jacques Genest;Ruth McPherson;Jiri Frohlich;Todd Anderson.
Canadian Journal of Cardiology (2009)
2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
Todd J. Anderson;Jean Grégoire;Robert A. Hegele;Patrick Couture.
Canadian Journal of Cardiology (2013)
Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy
Henian Cao;Robert A. Hegele.
Human Molecular Genetics (2000)
2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
Todd J. Anderson;Jean Grégoire;Glen J. Pearson;Arden R. Barry.
Canadian Journal of Cardiology (2016)
Hypertriglyceridemia: its etiology, effects and treatment
George Yuan;Khalid Z. Al-Shali;Robert A. Hegele.
Canadian Medical Association Journal (2007)
Current Opinion in Lipidology
(Impact Factor: 4.616)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: